A retrospective analysis of etiology and outcomes of hemophagocytic lymphohistiocytosis in children and adults
BACKGRUOUND: Hemophagocytic lymphohistiocytosis (HLH) is a rare but severe, life-threatening inflammatory condition if untreated. We aimed to investigate the etiologies, outcomes, and risk factors for death in children and adults with HLH.
METHODS: The medical records of patients who met the HLH criteria of two regional university hospitals in Korea between January 2001 and December 2019 were retrospectively investigated.
RESULTS: Sixty patients with HLH (35 children and 25 adults) were included. The median age at diagnosis was 7.0 years (range, 0.1-83 years), and the median follow-up duration was 8.5 months (range, 0-204 months). Four patients had primary HLH, 48 patients had secondary HLH (20 infection-associated, 18 neoplasm-associated, and 10 autoimmune-associated HLH), and eight patients had HLH of unknown cause. Infection was the most common cause in children (14/35, 40.0%), whereas neoplasia was the most common cause in adults (13/25, 52.0%). Twenty-eight patients were treated with HLH-2004/94 immunochemotherapy. The 5-year overall survival (OS) rate for all HLH patients was 59.9%. The 5-year OS rates for patients with primary, infection-associated, neoplasm-associated, autoimmune-associated, and unknown cause HLH were 25.0%, 85.0%, 26.7%, 87.5%, and 62.5%, respectively. Using multivariate analysis, neoplasm-induced HLH (p=0.001) and a platelet count <50×109/L (p=0.008) were identified as independent risk factors for poor prognosis in patients with HLH.
CONCLUSION: Infection was the most common cause of HLH in children, while it was neoplasia in adults. The 5-year OS rate for all HLH patients was 59.9%. HLH caused by an underlying neoplasm or a low platelet count at the time of diagnosis were risk factors for poor prognosis.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
---|---|
Enthalten in: |
Yeungnam University journal of medicine - 38(2021), 3 vom: 06. Juli, Seite 208-218 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kwak, Abraham [VerfasserIn] |
---|
Links: |
---|
Themen: |
Hemophagocytic lymphohistiocytosis |
---|
Anmerkungen: |
Date Revised 24.04.2022 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.12701/yujm.2020.00591 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM318089335 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM318089335 | ||
003 | DE-627 | ||
005 | 20231225164627.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.12701/yujm.2020.00591 |2 doi | |
028 | 5 | 2 | |a pubmed24n1060.xml |
035 | |a (DE-627)NLM318089335 | ||
035 | |a (NLM)33242384 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kwak, Abraham |e verfasserin |4 aut | |
245 | 1 | 2 | |a A retrospective analysis of etiology and outcomes of hemophagocytic lymphohistiocytosis in children and adults |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 24.04.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a BACKGRUOUND: Hemophagocytic lymphohistiocytosis (HLH) is a rare but severe, life-threatening inflammatory condition if untreated. We aimed to investigate the etiologies, outcomes, and risk factors for death in children and adults with HLH | ||
520 | |a METHODS: The medical records of patients who met the HLH criteria of two regional university hospitals in Korea between January 2001 and December 2019 were retrospectively investigated | ||
520 | |a RESULTS: Sixty patients with HLH (35 children and 25 adults) were included. The median age at diagnosis was 7.0 years (range, 0.1-83 years), and the median follow-up duration was 8.5 months (range, 0-204 months). Four patients had primary HLH, 48 patients had secondary HLH (20 infection-associated, 18 neoplasm-associated, and 10 autoimmune-associated HLH), and eight patients had HLH of unknown cause. Infection was the most common cause in children (14/35, 40.0%), whereas neoplasia was the most common cause in adults (13/25, 52.0%). Twenty-eight patients were treated with HLH-2004/94 immunochemotherapy. The 5-year overall survival (OS) rate for all HLH patients was 59.9%. The 5-year OS rates for patients with primary, infection-associated, neoplasm-associated, autoimmune-associated, and unknown cause HLH were 25.0%, 85.0%, 26.7%, 87.5%, and 62.5%, respectively. Using multivariate analysis, neoplasm-induced HLH (p=0.001) and a platelet count <50×109/L (p=0.008) were identified as independent risk factors for poor prognosis in patients with HLH | ||
520 | |a CONCLUSION: Infection was the most common cause of HLH in children, while it was neoplasia in adults. The 5-year OS rate for all HLH patients was 59.9%. HLH caused by an underlying neoplasm or a low platelet count at the time of diagnosis were risk factors for poor prognosis | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Hemophagocytic lymphohistiocytosis | |
650 | 4 | |a Human herpesvirus 4 | |
650 | 4 | |a Lymphoproliferative disorders | |
650 | 4 | |a Neoplasms | |
650 | 4 | |a Survival | |
700 | 1 | |a Jung, Nani |e verfasserin |4 aut | |
700 | 1 | |a Shim, Ye Jee |e verfasserin |4 aut | |
700 | 1 | |a Kim, Heung Sik |e verfasserin |4 aut | |
700 | 1 | |a Lim, Hyun Ji |e verfasserin |4 aut | |
700 | 1 | |a Lee, Jae Min |e verfasserin |4 aut | |
700 | 1 | |a Heo, Mi Hwa |e verfasserin |4 aut | |
700 | 1 | |a Do, Young Rok |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Yeungnam University journal of medicine |d 2018 |g 38(2021), 3 vom: 06. Juli, Seite 208-218 |w (DE-627)NLM302270043 |x 2384-0293 |7 nnns |
773 | 1 | 8 | |g volume:38 |g year:2021 |g number:3 |g day:06 |g month:07 |g pages:208-218 |
856 | 4 | 0 | |u http://dx.doi.org/10.12701/yujm.2020.00591 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 38 |j 2021 |e 3 |b 06 |c 07 |h 208-218 |